Unlocking the Microscopic Engines of Life EIT Hosts ODT 2026
Publisher:郭驰  Publish Time:2026-10-15  Views:21

Organelles are the microscopic engines that sustain life. They also offer a key entry point for understanding complex diseases and advancing precision diagnostics and therapy.

As precision medicine advances, biomedical research is moving beyond tissues and cells to investigate processes at the organelle level.

The ability to precisely characterize organelle function and achieve targeted regulation and intervention is critical to breakthroughs in the diagnosis and treatment of major diseases, including cancer, metabolic disorders and neurodegenerative diseases. It remains one of the most challenging questions at the forefront of biomedical science worldwide.

 The International Conference on Organelle Diagnostics and Therapy 2026 (ODT 2026) was held at the Eastern Institute of Technology, Ningbo (EIT), on September 18–19.

Under the theme “Focusing on Organelle Therapy and Charting New Frontiers in Precision Medicine,” the conference featured a main forum, an AI Virtual Cell Forum and a Young Scientists Forum.

More than 200 experts and scholars from eight countries gathered on the banks of the Yongjiang River to exchange insights into organelle functional imaging and regulation, antimicrobial susceptibility testing and treatment, organoid modeling and intelligent analysis, and spatial multi-omics profiling and applications.

Dongxiao Zhang delivers the opening address

At the opening ceremony, Dongxiao Zhang, Executive Vice President of EIT and a member of the U.S. National Academy of Engineering, delivered an address. He noted that EIT, a new research university founded on high standards with a compact scale, a focus on excellence, an innovative approach and an international outlook, has identified life and health sciences and the integration of medicine and engineering as key strategic priorities. The university has brought together leading talent from China and abroad and established a series of advanced research platforms. EIT will continue to build open and collaborative platforms for international exchange, support breakthroughs in precision diagnostics and therapy and their translation into practice, and explore new pathways linking frontier research with clinical applications.

Dayong Jin addresses the conference

Conference Chair Dayong Jin, Chair Professor at EIT and a Fellow of the Australian Academy of Technological Sciences and Engineering, highlighted the Zhejiang Provincial Engineering Research Center for Organelle Diagnostics and Therapy’s commitment to world-class research. By integrating biomedicine, engineering and information science, the center has pursued sustained research in key areas such as organelle functional regulation and nanomedicine delivery, producing a series of landmark original findings. Guided by real clinical needs, the center works closely with more than ten leading medical institutions in China to advance collaboration between medicine and engineering and multicenter clinical validation. Jin expressed his hope that the conference would strengthen cooperation with research teams in China and overseas and help open new horizons in precision medicine.

The Zhejiang Provincial Engineering Research Center for Organelle Diagnostics and Therapy was established in 2024 with approval from the Zhejiang Provincial Development and Reform Commission. EIT serves as the lead institution, and Dayong Jin is the center’s director.

At the main forum, international experts including Professor Thomas Simmen of the University of Alberta, Canada; Professor Sebastian Hiller of the University of Basel, Switzerland; Professor Shigeru Yanagi of Gakushuin University, Japan; Stefan Schild from Austria; Felipe Cava from Sweden; and Daniel López from Spain shared their latest findings on mitochondrial regulation and replacement therapy, organelle homeostasis and mechanisms of cell death, and bacterial membrane microdomains and extracellular vesicles.

Xing-jie Liang presents his research

Conference Co-Chair Xing-jie Liang, a member of the Academia Europaea, presented advances in nanoparticle-mediated regulation of the lysosome–mitochondria interactome. Other speakers included Associate Professor Liang Ge of Tsinghua University; Professor Junjie Hu of the Institute of Biophysics, Chinese Academy of Sciences; Professor Da Jia of Sichuan University; Professor Yang Tian of East China Normal University; Professor Boxun Lu of Fudan University; Professor Jiangli Fan of Dalian University of Technology; Research Professor Cunqi Ye and Professor Jiaming Chen of Zhejiang University; and Professor Dan Ye of Fudan University. Their presentations highlighted advances achieved through interdisciplinary research in unconventional secretion, probes for super-resolution imaging, mechanisms of neurodegenerative diseases and immunometabolism.

Roundtable discussion on virtual cells

The conference also featured an AI Virtual Cell Forum and a Young Scientists Forum. The AI Virtual Cell Forum covered virtual cell development, dynamic virtual cell agents, deep learning-enhanced mitochondrial imaging and multimodal data acquisition for organoids. It also included project pitches and a roundtable on industry investment. Industry representatives presented technology platforms for super-resolution microscopy with high spatial and temporal resolution, mitochondrial vesicle characterization and high-content cell mapping, discussing how advanced instruments and tools can be translated into applications in basic research and drug screening.

 At the Young Scientists Forum, more than ten early-career scientists shared their latest breakthroughs and advances across emerging interdisciplinary fields. Topics included nanoprobes and bioimaging, precision cancer diagnostics and therapy, targeted drug delivery, in vivo peptide self-assembly, neural regulation through electrical stimulation, micro- and nanomanipulation robots, extracellular vesicles and engineered living biotherapeutics, and the regulation of development by ancient retroviruses.

Participants agreed that the conference strengthened connections across the full continuum of basic research, technology development, clinical application and industry investment, providing a high-level platform for international collaboration in the emerging interdisciplinary field of organelle biology. Looking ahead, EIT will continue to draw on advanced research platforms, including the Zhejiang Provincial Engineering Research Center for Organelle Diagnostics and Therapy, to bring together global innovation resources and accelerate the translation of frontier research into practical applications, contributing to the advancement of precision medicine and the life and health sciences industry.

Conference participants gather for a group photograph

The conference was jointly hosted by EIT and the Zhejiang Provincial Engineering Research Center for Organelle Diagnostics and Therapy, with support from the Ningbo Science and Technology Innovation & Development Service Center and Ningbo No. 2 Hospital, and organized by Ningbo EIT Digital Biotechnology Co., Ltd.

Attendees also included Jianjun Zheng, Party Committee Secretary, and Boding Wang, President, of Ningbo No. 2 Hospital; Honghua Ye, President of Ningbo Medical Center Lihuili Hospital; Hongfei Weng, Party Committee Secretary, Jiawei Zhou, Executive President, and Quanyong Yi, Vice President, of Ningbo Eye Hospital; and Tao Li, Party Committee Secretary of Ningbo No. 6 Hospital. Representatives from the First Affiliated Hospital of Ningbo University and Ningbo Hospital of Integrated Traditional Chinese and Western Medicine also attended. Together, they explored new approaches to integrating medicine and engineering and translating advanced diagnostic and therapeutic technologies into clinical practice.


Top Articles